Is Beijing Hotgen Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Beijing Hotgen Biotech pays dividends. Last time was Wednesday 3rd of July 2024 where the investors holding the stock on Wednesday 3rd of July 2024 were paid CNY0.2 per share. Over the last 4 times between 2020 and 2024, Beijing Hotgen Biotech has paid CNY9.4 with an average of CNY2.35 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Beijing Hotgen Biotech 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was CNY40.27, you would have made a loss of CNY-12.16 per share or -30.20%
Yes, the average daily trading liquidity for Beijing Hotgen Biotech is CNY1.02 million. You should therefore be able to get in and out of your positions relatively fast.
Beijing Hotgen Biotech has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 26.91, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Beijing Hotgen Biotech to be low [0.3 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.